The effect of perphenazine-induced serum prolactin response on estrogen-primed mammary tumor-host systems, 13762 and R-35 mammary adenocarcinomas.
D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D008321:Mammary Glands, Animal / Q000254:growth & development* / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D009368:Neoplasm Transplantation; D009929:Organ Size; D010546:Perphenazine / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay; D051381:Rats; D013997:Time Factors; D014184:Transplantation, Homologous
D004958:Estradiol; D011388:Prolactin; D010546:Perphenazine